Search for Clinical Trial Results

Scleroderma, Limited - 8 Studies Found
Status | Study |
Completed |
Study Name: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma Condition:
Date: 2013-06-05 |
Completed |
Study Name: Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis Condition:
|
Completed |
Study Name: Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet Condition: Ischemia Date: 2010-02-19 Interventions: Drug: ambrisentan Subjects will receive ambrisentan 5 mg orally once daily or identical placebo pills fo |
Withdrawn |
Study Name: Systemic Sclerosis Clinical and Biomarker Study Condition:
Date: 2015-08-20 |
Recruiting |
Study Name: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Condition:
|
Completed |
Study Name: Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine Condition:
Date: 2008-10-17 Interventions:
|
Terminated |
Study Name: Exparel as a Nerve Block for Severe Hand Pain Condition:
|
Terminated |
Study Name: Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft Condition:
Date: 2010-05-27 Interventions:
|